RPG Life Sciences (BOM:532983) Total Liabilities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences Total Liabilities?

RPG Life Sciences's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil.

RPG Life Sciences's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹1,749.90 Mil) but then declined from Sep. 2024 (₹1,749.90 Mil) to Dec. 2024 (₹0.00 Mil).

RPG Life Sciences's annual Total Liabilities increased from Mar. 2022 (₹888.40 Mil) to Mar. 2023 (₹1,117.50 Mil) and increased from Mar. 2023 (₹1,117.50 Mil) to Mar. 2024 (₹1,380.20 Mil).

RPG Life Sciences Total Liabilities Historical Data

The historical data trend for RPG Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences Total Liabilities Chart

RPG Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

901.60

869.40

888.40

1,117.50

1,380.20

RPG Life Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	1,380.20	-	1,749.90	-

RPG Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RPG Life Sciences's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1309.6	+	(0	+	30.3
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	40.3	+	0)
	=	1,380

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	5128.7	-	3748.5
	=	1,380

RPG Life Sciences's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

RPG Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

RPG Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (BOM:532983) » Definitions » Total Liabilities

Traded in Other Exchanges

RPGLIFE:India

Address

463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030

Website

https://www.rpglifesciences.com

RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines